A mechanism research of novel inhibitor of PAK1 inducing colorectal cancer DLD-1 apoptosis

WANG Jiaqi; CHEN Jiao; SUN Xiaoyan; LU Wuguang; YANG Yang; CAI Xueting; WANG Xiao-ning; CAO Peng

doi:10.11665/j.issn.1000-5048.20180214

Journal of China Pharmaceutical University > 2018 > 49(2): 229-237. > DOI: 10.11665/j.issn.1000-5048.20180214

WANG Jiaqi, CHEN Jiao, SUN Xiaoyan, LU Wuguang, YANG Yang, CAI Xueting, WANG Xiao-ning, CAO Peng. A mechanism research of novel inhibitor of PAK1 inducing colorectal cancer DLD-1 apoptosis[J]. Journal of China Pharmaceutical University, 2018, 49(2): 229-237. DOI: 10.11665/j.issn.1000-5048.20180214

Citation:

PDF (3545 KB)

A mechanism research of novel inhibitor of PAK1 inducing colorectal cancer DLD-1 apoptosis

More Information

Graphical Abstract

Abstract

Abstract

PAK1 plays an important role in the development of tumors. It is of great significance to screen and develop new PAK1 inhibitors as targeted drugs for cancer treatment. The traditional PAK1 inhibitor screening method has the problems of high cost and low efficiency. Computer virtual screening can reduce the cost of finding active lead compounds and improve the screening efficiency. In this study, a kind of PAK1 candidate compound was screened by computer assisted virtual screening combined with Z′lyte^TM high flux kinase screen. In vitro enzyme activity screening showed that compound 18(K788)had good PAK1 inhibitory activity(inhibition rate was 42. 7%). Furtherly by MTT detection, it was found that K788 had significant PAK1 positive tumor killing activity, which was even better than the positive drug IPA-3. Flow cytometry and Western Blot showed that K788 could activate caspase apoptosis pathway and induce apoptosis of colon cancer cell DLD-1 by inhibiting PAK1 expression and activation. K788 has great potential for clinical development and application, and can be used as a PAK1 target for further research.
- CADD,
- PAK1,
- kinase activity,
- proliferation inhibition,
- pro-apoptosis

FullText(HTML)

References (14)

References

[1]	Radu M,Semenova G,Kosoff R,et al.PAK signalling during the development and progression of cancer[J].Nat Rev Cancer,2014,14(1):13-25.
[2]	Kumar R,Vadlamudi RK.Emerging functions of p21-activated kinases in human cancer cells[J].J Cell Physiol,2002,193(2):133-144.
[3]	Sells MA, Knaus UG, Bagrodia S, et al. Human p21-activated kinase(PAK1)regulates actin organization in mammalian cells[J].Curr Biol,1997,7(3):202-210.
[4]	Delorme V,Machacek M,Dermardirossian C,et al.Cofilin activity downstream of Pak1 regulates cell protrusion efficiency by organizing lamellipodium and lamella actin networks[J].Dev Cell,2007,13(5):646-662.
[5]	Balasenthil S,Sahin AA,Barnes CJ,et al.P21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells[J].J Biol Chem,2004,279(2):1422-1428.
[6]	Schraml P,Schwerdtfeger G,Burkhalter F,et al.Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma[J].Am J Pathol,2003,163(3):985-992.
[7]	Ito M,Nishiyama H,Kawanishi H,et al.P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer[J].J Urol,2007,178(3):1073-1079.
[8]	Vadlamudi RK,Adam L,Wang RA,et al.Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells[J].J Biol Chem,2000,275(46):36238-36244.
[9]	Wang RA,Zhang H,Balasenthil S,et al.PAK1 hyperactivation is sufficient for mammary gland tumor formation[J].Oncogene,2006,25(20):2931-2936.
[10]	Dummler B,Ohshiro K,Kumar R,et al.Pak protein kinases and their role in cancer[J].Cancer Metast Rev,2009,28(1/2):51-63.
[11]	Sala-Vila A,Folkes J,Calder PC.The effect of three lipid emulsions differing in fatty acid composition on growth,apoptosis and cell cycle arrest in the HT-29 colorectal cancer cell line[J].Clin Nutr,2010,29(4):519-524.
[12]	Rudolph J,Crawford JJ,Hoeflich KP,et al.Inhibitors of p21-activated kinases(PAKs)[J].J Med Chem,2015,58(1):111.
[13]	Ndubaku CO,Crawford JJ,Drobnick,J,et al.Design of selective PAK1 inhibitor G-5555: improving properties by employing an unorthodox low-pKa polar moiety[J].ACS Med Chem Lett,2015,6(12):1241-1246.
[14]	Beck JT,Ismail A,Tolomeo C.Targeting the phosphatidylinositol 3-kinase(PI3K)/AKT/mammalian target of rapamycin(mTOR)pathway: an emerging treatment strategy for squamous cell lung carcinoma[J].Cancer Treat Rev,2014,40(8):980-989.

Cited By

Get Citation

PDF

XML

Article views (883) PDF downloads (1499)

Turn off MathJax

Article Contents

Abstract

References

A mechanism research of novel inhibitor of PAK1 inducing colorectal cancer DLD-1 apoptosis

Abstract

References

Catalog

Export File

Citation

Format

Content